ABSTRACT
Cigarette smoking is prevalent in pregnant substance users but receives low priority in substance use disorder treatment. This article reports the results of a secondary analysis of a randomized, multisite trial with 200 pregnant substance users, 145 (72.5%) of whom smoked at baseline. As predicted: (1) smokers had significantly greater substance use; (2) approximately half of smokers wanted to quit; and (3) smokers with a quit goal had significantly greater self-efficacy and lower perceived difficulty of quitting. Smoking may be associated with more severe substance use in pregnant substance-using patients, half of whom may be interested in smoking-cessation interventions.
KEYWORDS:
Funding
This work was supported by a series of grants from National Institute on Drug Abuse (NIDA) as part of the Cooperative Agreement on National Drug Abuse Treatment Clinical Trials Network (CTN) in the Ohio Valley Node (U10DA013732), the North Carolina Node (U10DA013711), and the Southwest Node (U10DA015833). NIDA had no further role in study design or in the collection, analysis, and interpretation of data. NIDA Center for the Clinical Trials Network (CCTN) personnel contributed to the design of the original study and CCTN contractors played a role in the collection and analysis of data from the original study. NIDA had no further role in the design of this analysis, in the manuscript writing of the report, or in the decision to submit the article for publication. ClinicalTrials.gov Identifier: NCT00078143.